Flubrotizolam presents itself as a novel benzodiazepine analogue. Developed for medical purposes, flubrotizolam possesses powerful sedative effects. Its pharmacological properties illustrate a high affinity for the GABA receptor, resulting significant CNS depression. Despite its potential pharmaceut